Orencia clickject 125 MG/mlml
Ended Awarded
- Contract number
- SPE2DB25FAVYR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,399
Award facts
- Contract value 100% obligated
- $35,399.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $35,399.33, represents a firm fixed-price award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Orencia ClickJect 125 mg/ml. The Defense Logistics Agency issued this award on August 8, 2025, with an ultimate completion date of August 11, 2025, with no set-aside designation applied. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes firm fixed-price orders for a comprehensive range of pharmaceutical products supporting Department of Defense medical supply requirements.
Orencia ClickJect is a biologic medication used in the treatment of autoimmune conditions, and this delivery order fulfills immediate pharmaceutical supply needs for military health facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its consistent contract awards with the Defense Logistics Agency, delivering an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables to military healthcare systems nationwide. The company's positioning as a woman-owned small business, combined with its comprehensive pharmaceutical distribution capabilities, enables it to effectively compete in federal procurement markets and support the Department of Defense's medical readiness requirements.
Quick answers
Who was awarded contract SPE2DB25FAVYR?
SPE2DB25FAVYR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FAVYR worth?
The government has obligated $35,399 on SPE2DB25FAVYR.
Is contract SPE2DB25FAVYR an order under another contract?
Yes. SPE2DB25FAVYR is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVYR competed?
The extent of competition for SPE2DB25FAVYR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award